TrialSite has reported on news around the nation that at least some of the pivotal Phase 3 vaccine studies are struggling to enroll sufficient numbers of minority participants, particularly African Americans and Hispanics. Just recently in New Jersey, for example,...
Minority Participation in Clinical Trials
Category
Failure to Recruit Minorities May Slow COVID-19 Vaccine Approval
As reported August 16 by CNN, our efforts to find a COVID-19 vaccine may be delayed as not enough minorities have been recruited to join trials. Out of 350,000 people who have registered for a trial, 10% are Latino or Black, according to Dr. Jim Kublin of the Covid-19...
ACCC Joins ASCO in Efforts to Improve Minority Representation in Cancer Clinical Trials
The Association of Community Cancer Centers (ACCC) has partnered with the American Society of Clinical Oncology (ASCO) in a collaborative effort to improve the participation of racial and ethnic minority populations in cancer clinical trials. The organizations call on...
Minority Populations Underreported & Underrepresented in AFib Trials
Participant-level racial/ethnic minority data are reported inconsistently and heterogeneously in contemporary guideline-informing atrial fibrillation (AFib) clinical trials, according to a study published June 15 in JACC: Clinical Electrophysiology. Ashish Sarraju,...
Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials
CTTI is hosting a timely webinar Thursday June 18 at Noon ET to discuss the importance and urgency of meaningful engagement of racial and ethnic minority communities in COVID-19 clinical trials. Using insights gleaned from a survey of key stakeholders across the...
University of Alabama Research Studies Whether Bias is Impacting Cancer Clinical Trials’ Participation
The University of Alabama at Birmingham recently completed a study raising questions about racial bias in cancer research trials. Apparently, a subtle, or in some case not-so-subtle, bias against racial minorities—especially Blacks and Latinos—could, in some cases,...
Entertainment Industry-backed “Stand Up to Cancer” Targets Underrepresented Minorities Populations for Clinical Trial Participation
Stand Up to Cancer (SU2C) announced its initiative to increase minority representation in cancer and clinical trials. This initiative is aimed at reducing racial and ethnic disparities in cancer research and improving outcomes for minority populations. They will fund...
Lupus Foundation of America: Project IMPACT for Increasing Minority Participation in Lupus Clinical Trials
The IMPACT project is a faith-based approach to increasing awareness and participation in lupus clinical trials. The project has a Community Advisor Board that has developed training materials on participation in lupus clinical trials. Project IMPACTIncreasing...
Lazarex Foundation Funded IMPACT Trial; Ensuring The Possibility For USC to Enroll Underrepresented Minorities into Cancer Study
ABC7 reports in Los Angeles, CA that University of Southern California (USC) clinical researchers are offering financial aid to prospective participants to join clinical studies. TrialSite News picked up on this program some months ago as USC has identified some...
Diversifying Cancer Trials: An Innovative New Approach Merits a Close Look
University of Southern California (USC) Comprehensive Cancer Center and Lazarex Cancer Foundation report to be “making history” by introducing the new IMPACT program: Improving Patient Access to Cancer Clinical Trials. The duo report it is the first type of program...
The IMPACT Trial: UCSF Targets More Diversity in Clinical Trials
Elizabeth Fernandez of University of California, San Francisco reports that UCSF is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved...
Lack of Diversity In Clinical Research Merits Another Study– Really?
Bloomberg Law reports on recent activity on Capitol Hill involving clinical trials barriers and minorities, the poor, women and aging. Rep. Elijah Cummings (D-Md) would ensure the GAO study the barriers at the Department of Defense and Veterans Affairs, the National...
Almost One-Fifth of USA are Latino But Only 5% Participate in Clinical Trials—What’s Wrong?
Latino USA reports that while Latinos represent close to 18 percent of the population in the United States, fewer than five percent participate in clinical trials. For advocates who push for greater participation in the Latino community, this is a problem, and being...
Baylor Leads Autism Study Focusing on Underrepresented Communities
Baylor College of Medicine reports that a new grant to Baylor College of Medicine will build on the ongoing SPARK for Autism study, focusing on fighting disparities and lack of diversity in autism research. SPARK (Simons Foundation Powering Autism Research for...
Hollings Cancer Center Supports Designs to Include Minorities in Cancer Clinical Trials
As reported in EurekAlert!, Marvella Ford, Ph.D. of the Hollings Cancer Center of the Medical University of South Carolina, as well as eight other cancer centers, has participated in an important study focusing on how to overcome disparities in cancer clinical...
African Americans & Latinos Poorly Represented in Asthma Clinical Trials
Unsurprisingly, there is yet another report that ethnic minorities are underrepresented in critical clinical trials. We at TrialSite News have done an original survey in Southeast Texas focusing on African Americans and clinical trials. In the case of asthma as...
Wisconsin Alzheimer’s Institute Seeking Minorities for Clinical Trial
As reported in WSAW Fox, The Wisconsin Alzheimer’s Institute is looking for minorities to take part in a family history study of Alzheimer’s disease. Specifically, researchers are looking for people who are African-American and Latino to better understand why...
FDA EFIC and African American Mistrust of Clinical Research
Harvard recently completed a study we link to here. FDA Exception for Informed Consent trials are applied to investigative therapies for people impacted by life-threatening conditions—e.g. cardiac arrest, etc. They need immediate treatment prior to ability to provide...
Consider Nurses to Help Improve Racial and Ethnic Disparities in Clinical Research
It is known in the clinical research world that disparities exist when it comes to clinical trials participation. In fact in some sectors of research this represents a significant problem including Alzheimer's Disease, Oncology, etc. Moreover there is plenty of...
African Americans Urged to Consider Clinical Trials
An initiative launched today encourages newly-diagnosed African American cancer patients in Maryland to consider clinical trials as the first-line option, not the last resort. The effort is spearheaded by Advancing Cancer Treatment (ACT), a philanthropic initiative...